Human immunodeficiency virus (HIV) transmission remains
significant in Europe. Rates of acquired immunodeficiency syndrome (AIDS) have
declined, but not in all countries. New HIV diagnoses have increased among
native and foreign-born men who have sex with men. Median CD4+ T-cell count at diagnosis
has increased, but not in all groups, and late diagnosis remains common. HIV
infection and AIDS can be eliminated in Europe with resolute prevention
measures, early diagnosis and access to effective treatment.
In 2014, 29,992 people were newly diagnosed with HIV in the
EU/EEA, a rate of 5.9 diagnoses per 100,000 population. The majority of cases
(76.8%) were men (9.2 per 100,000 population vs 2.6 in women). This was largely
driven by HIV transmission attributed to sex between men, which accounted for
12,677 (42%) of all HIV diagnoses. A total of 9,833 cases (33%) were attributed
to heterosexual contact, 1,244 (4%) to injecting drug use, and for 5,908 (20%)
of new diagnoses, the transmission mode was not reported or unknown.
Below: Proportion of new HIV diagnoses with known mode of transmission, by country, transmission route and migration status, EU/EEA, 2014 (n = 22,443)
Below: New HIV diagnoses, by year of diagnosis, transmission and migration status, adjusted for reporting delay, EU/EEA, 2005–2014 (n = 193,761)
Below: New AIDS diagnoses, by transmission and migration status, EU/EEA, 2005–2014 (n = 55,760)
Below: Proportion of HIV diagnoses by CD4+ T-cell count/mm3 category at diagnosis, all cases and by transmission mode and migration status, EU/EEA, 2014 (n = 18,467)
Below: Trends in median CD4+ T-cell count/mm3 at HIV diagnosis, by year of diagnosis, transmission group and migration status, EU/EEA, 2005–2014 (n = 115,149)
Full article at: http://goo.gl/CgyFjy
By: A Pharris 1 , C Quinten 1 , L Tavoschi 1 , G Spiteri 1 , AJ Amato-Gauci 1 , the ECDC HIV/AIDS Surveillance Network 2
1. European Centre for Disease Prevention and
Control (ECDC), Stockholm, Sweden
2. The members of the network are listed at the
end of the article
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment